We propose that the Invitrogen SuperScript® III Reverse Transcriptase kit is the most suitable, among the ones used in this study, for the cDNA synthesis to be used for the detection of BCR-ABL1 at the MMR level in a CML MRD assay. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.